Legend Biotech Corporatio... (LEGN)
36.51
-0.13 (-0.35%)
At close: Jan 28, 2025, 2:55 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -20.44 | -17.79 | -17 | -10.96 | -36.73 | -1.33K | 521.54 |
| PS Ratio | 37.16 | 67.86 | 73.11 | 43.97 | 85.29 | 75.31 | 207.01 |
| PB Ratio | 8.47 | 10.67 | 13.93 | 11.87 | -39.75 | 427.80 | 401.47 |
| P/FCF Ratio | -25.47 | -35.71 | -26.73 | -12.2 | -39.96 | 12.91 | -1.50K |
| P/OCF Ratio | -26.94 | -39.69 | -33.08 | -14.92 | -58.8 | 12.03 | -2.06K |
| OCF/S Ratio | -1.38 | -1.71 | -2.21 | -2.95 | -1.45 | 6.26 | -0.1 |
| Debt / Equity Ratio | 0.26 | 0.38 | 0.26 | 0.01 | -0.05 | 0.50 | 0.02 |
| Quick Ratio | 6.83 | 3.66 | 3.38 | 3.67 | 1.61 | 2.05 | 4.43 |
| Current Ratio | 6.92 | 3.69 | 3.39 | 3.68 | 1.62 | 2.05 | 4.43 |
| Asset Turnover | 0.15 | 0.09 | 0.08 | 0.10 | 0.20 | 0.11 | 0.10 |
| Interest Coverage | -20.17 | -42.22 | -436.69 | -74.45 | -586.87 | -18.71 | n/a |
| Return on Equity (ROE) | -0.41 | -0.6 | -0.82 | -1.08 | 1.08 | -0.32 | 0.77 |
| Return on Assets (ROA) | -0.28 | -0.34 | -0.35 | -0.42 | -0.46 | -0.01 | 0.04 |
| Return on Capital (ROIC) | -0.27 | -0.44 | -0.47 | -0.56 | -0.82 | -0.01 | 0.07 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 49.42% | 44.14% | -248.97% | -206.78% | 100.00% | 100.00% | 100.41% |
| Net Profit Margin | -181.75% | -381.48% | -430.12% | -401.02% | -232.21% | -5.67% | 39.69% |
| Pretax Profit Margin | -182.41% | -380.94% | -430.11% | -406.5% | -227.66% | -3.29% | 58.65% |
| Operating Profit Margin | -154.13% | -389.58% | -437.71% | -414.06% | -228.54% | -3.12% | 58.41% |
| FCF Margin | -145.89% | -190% | -273.5% | -360.46% | -213.46% | 583.44% | -13.83% |
| EBITDA Margin | -167.59% | -356% | -436.99% | -388.69% | -218.09% | 0.30% | 59.57% |